Is GuineaPig free to use?

Yes, completely free. GuineaPig pulls data from ClinicalTrials.gov and adds compensation estimates, eligibility matching, and category filters to make it easier to browse. We don't charge volunteers or collect payment information.

How does GuineaPig estimate compensation?

Pay ranges are rough estimates based on the study's phase, duration, and typical industry rates. Phase 1 inpatient studies tend to pay the most because they require overnight stays. These are not confirmed by sponsors — always contact the study team directly for the actual compensation.

How often is trial data updated?

Trial listings are pulled from ClinicalTrials.gov in real time. New studies appear as soon as sponsors register them with the NIH. Study status, enrollment counts, and location data are updated whenever sponsors submit changes to the registry.

Does GuineaPig screen me or sign me up?

No. GuineaPig is a search tool only. When you find a trial you're interested in, click 'View on ClinicalTrials.gov' to get the study team's contact information. You'll go through the sponsor's own screening and enrollment process.

Neonatal Platelet Transfusion Threshold Trial

Sponsor

NICHD Neonatal Research Network

Pharma

Typical Pay Range

$50 – $1,000

Illustrative estimate only - not verified by this sponsor. Contact the study team for actual compensation.

About This Study

The objective of the NeoPlaTT trial is to test whether, among extremely preterm infants born at 23 0/7 to 26 6/7 weeks' gestation, a lower platelet transfusion threshold, compared to a higher threshold, improves survival without major or severe bleeding up to 40 0/7 weeks' postmenstrual age (PMA).

Your Journey

What happens when you apply

📞

Contact Study Team

5 min

Reach out via phone or email to express interest

💬

Phone Screening

15-30 min

Brief call to discuss your health history

🏥

In-Person Visit

2-4 hours

Medical screening at the research site

🚀

Start Participation

Varies

Begin your journey in the study

Questions to Ask

What's the exact compensation schedule?

What are the potential side effects?

Can I withdraw at any time?

Phase

N/A

Enrollment

2,433 participants

Sites

20 locations

Timeline

Jun 2025 - Jan 2031

What's Involved

Higher Platelet Transfusion ThresholdLower Platelet Transfusion Threshold

Conditions Studied

ThrombocytopeniaNeonatalPlatelet TransfusionInfant, Newborn, DiseasesInfant, Extremely Low Birth WeightInfant, Small for Gestational AgeThrombosis

Study Locations

University of Alabama at Birmingham

Birmingham, Alabama, United States

Stanford University

Palo Alto, California, United States

Sharp Mary Birch Hospital for Women & Newborns

San Diego, California, United States

University of Colorado

Aurora, Colorado, United States

Emory University

Atlanta, Georgia, United States

Eligibility

Min Age:1 Hour

Max Age:48 Hours

Sex:ALL

Full Criteria

Inclusion Criteria:

* Gestational age of 23 0/7 to 26 6/7 weeks
* Postnatal age of \< 48 hours

Exclusion Criteria:

* Comfort care or withdrawal of care planned
* Neonatal alloimmune thrombocytopenia or suspected/confirmed congenital platelet or bleeding disorder
* Receipt of platelet transfusion
* No receipt of Vitamin K
* Parents/guardian decline consent

NCT06676904

View on ClinicalTrials.gov Browse More Trials

More Pharma Trials

Browse all Pharma trials

Trials by City

Birmingham, Alabama Palo Alto, California San Diego, California Aurora, Colorado Atlanta, Georgia Chicago, Illinois

imaguineapig pulls live data from ClinicalTrials.gov (NIH/NLM).Illustrative estimate only - not verifiedPay estimates are approximate ranges based on study type and are not confirmed by sponsors — actual compensation may differ. Eligibility indicators use limited criteria (age, sex) only. We do not provide medical advice. Always contact the study team directly to confirm compensation, full eligibility, and risks before enrolling.